69739-16-8 Cefodizime AKSci K170
 
 
Loading Please Wait...
  K170    AKSci Reference Standard
Cefodizime
, 97% (HPLC)
 



IDENTITY
CAS Number:69739-16-8
MDL Number:MFCD00864926
MF:C20H20N6O7S4
MW:584.67
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:97% (HPLC)
Physical Form (at 20°C):Solid
Melting Point:204-223°C
Long-Term Storage:Store long-term at -20°C
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

REVIEW

 Cefodizime is a third generation cephalosporin beta lactam with a broad spectrum of antibacterial activity and immunomodulating activity, and used in the treatment of otitis media, sinusitis and gynaecological infections, and for the prophylaxis or treatment of surgical infections. Cefodizime inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs). This inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested.Cefotaxime sodium is used in combination with sulbactam sodium, a beta-lactamase inhibitor for use as an injectable. The sulbactam sodium inhibiting beta-lactamase, which would otherwise deactivate the cefodizime.

REFERENCES
[1]Le Noc P; Bryskier A; Le Noc D In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime Pathologie-biologie (1985), 33(5), 399-403.
[2] Blumbach J, Dürckheimer W, Ehlers E, Fleischmann K, Klesel N, Limbert M, Mencke B, Reden J, Scheunemann KH, Schrinner E. Cefodizime, an aminothiazolylcephalosporin. V. Synthesis and structure-activity relationships in the cefodizime series. J Antibiot (Tokyo). 1987 Jan;40(1) 29-42. PMID: 3558116.
[3] Jaenicke, Ottmar; Wagner, Hans; Worm, Manfred Procedure for the preparation of cefodizime Ger. Offen. (1987), DE 3542644 A1 19870604.
[4] Labro MTCefodizime as a biological response modifier: a review of its in-vivo, ex-vivo and in-vitro immunomodulatory properties. J Antimicrob Chemother. 1990 Nov;26 Suppl C:37-47.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Warning

Hazard Statements
H315; H319; H335

Precautionary Statements
P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501


RELATED PRODUCTS
K170Cefodizime
O767Cefodizime sodium

Current as of April 16, 2024

AKSci Reference Standards are high-purity, low-impurity compounds suitable for use as standards.


Download SDS Request COA

All products are stocked and shipped from San Francisco Bay Area, California, USA.

⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.



CATEGORIES

 APIs and Bioactives > Antibacterials, Cephalosporins


PubChem
  @PubMed